Quick Facts at a Glance
- Recall Date
- January 26, 2026
- Hazard Level
- HIGH
- Brand
- F.H. INVESTMENTS, Inc.
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- F.H. INVESTMENTS, Inc.
- Product type
- Estradiol Pellet
- Model numbers
- Lot#: 253000118, Exp. 02/21/2026, 253000145, Exp. 08/02/2026, 253000146, Exp. 06/30/2026, 253000167, Exp. 09/23/2026.
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
January 26, 2026
Reported by FDA DRUG
February 18, 2026
RecallRadar source check
February 25, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Presence of Foreign substance - potential presence of metal particulate matter
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact F.H. INVESTMENTS, Inc. (dba Asteria Health) or your healthcare provider for guidance. Notification method: Letter
About This Product
Estradiol pellets are used in hormone replacement therapy for treating symptoms of menopause and other hormonal imbalances. They provide a controlled release of estrogen into the body to alleviate symptoms.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face health risks from using the affected estradiol pellets. The urgency to stop use and seek guidance adds to the inconvenience of managing hormonal therapy.
Practical Guidance
How to identify if yours is affected
- Check the packaging for the NDC number: 79559-3015-32.
- Confirm the expiration dates listed on the product.
Where to find product info
You can find the NDC number, lot numbers, and expiration dates on the product packaging or prescription label.
What timeline to expect
Expect a refund processing timeline of approximately 4-6 weeks after contacting the manufacturer.
If the manufacturer is unresponsive
- Document all communication attempts with the company.
- Consider contacting the FDA for additional guidance.
- Keep records of your purchase and any correspondence.
How to prevent similar issues
- Always check for recalls of medications before use.
- Consult with a healthcare provider for alternative treatments if recalls occur.
- Be aware of the signs of contamination in pharmaceutical products.
Documentation advice
Keep a copy of your purchase receipt, any correspondence with the manufacturer, and photographs of the product as evidence.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recalled product is ESTRADIOL, 15 mg, 1 Sterile Pellet, with NDC: 79559-3015-32. It was distributed nationwide in the USA. The affected lot numbers include 253000118, 253000145, 253000146, and 253000167, with expiration dates ranging from June 30, 2026, to September 23, 2026.
Key Facts
- Recall Date: January 26, 2026
- Quantity Recalled: 14,848 pellets
- Hazard Level: High
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.